Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
International Journal of Bio-Medical Computing|June 1, 1994
Computation of drug concentrations in endocardial vegetations in patients during antibiotic therapyP Maire, X Barbaut, J M Vergnaud, et al.
BMJ Open|September 23, 2019
Feasibility of individualised severe traumatic brain injury management using an automated assessment of optimal cerebral perfusion pressure: the COGiTATE phase II study protocolErta Beqiri, Peter Smielewski, Chiara Robba, et al.
Radiation Oncology (London, England)|August 14, 2015
French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patientsV Vendrely, B Henriques de Figueiredo, E Rio, et al.
Acta Neurochirurgica. Supplement|April 11, 2021
Optimal Cerebral Perfusion Pressure Assessed with a Multi-Window Weighted Approach Adapted for Prospective Use: A Validation StudyErta Beqiri, Ari Ercole, Marcel J Aries, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 16, 1999
[Fractionated radiotherapy of intracranial meningiomas: 15 years' experience at the Bordeaux University Hospital Center]V Vendrely, J P Maire, V Darrouzet, et al.
Histopathology|August 10, 2000
Distinction between coeliac disease and refractory sprue: a simple immunohistochemical methodN Patey-Mariaud De Serre, C Cellier, B Jabri, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 1999
Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP)C Carrie, S Hoffstetter, F Gomez, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 27, 2007
[French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins]G Kantor, M-A Mahé, P Giraud, et al.
Gastroenterology|April 28, 2000
Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac diseaseB Jabri, N P de Serre, C Cellier, et al.
Revue Neurologique|June 21, 2008
[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study]S Guiu, S Taillibert, O Chinot, et al.
Pageof 20